DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Kodaman PH, Duleba AJ.
HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?.
Drugs 2008;
68: 1771-1785
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.